NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer
Jensen, Lars Henrik, Olesen, René, Petersen, Lone Noergaard, Boysen, Anders Kindberg, Andersen, Rikke Fredslund, Lindebjerg, Jan, Nottelmann, Lise, Thomsen, Caroline Emilie Brenner, Havelund, BirgitteТом:
11
Мова:
english
Журнал:
Cancers
DOI:
10.3390/cancers11111649
Date:
October, 2019
Файл:
PDF, 1.23 MB
english, 2019
File converter
Більше результатів пошуку
More benefits 
